Fintech PR

String of Legal Victories Puts CBD and Cannabis into International Spotlights

Published

5 years ago

April 9, 2019

Newsfile

Reading Time: 5 minutes

Over the past couple of years, cannabis has become a major topic in many countries’ agendas due to its therapeutic benefits. Regulators worldwide are now exploring opportunities within the cannabis market as it can be used as an alternative to certain traditional medical treatments. In particular, the U.S. marketplace is expected to be one of the most explosive markets. Despite cannabis still being federally illegal within the U.S., certain states, such as California and Colorado, which have legalized recreational cannabis contribute billions of dollars in revenue annually. Moreover, cannabidiol or CBD-based products have become increasingly common across the U.S. In late 2018, U.S. President Donald Trump signed the U.S. Farm Bill into effect, allowing the production of hemp. Shortly after, convenience stores and pharmacies began carrying hemp-derived CBD products. Even major pharmaceutical chains have begun to carry CBD products, promoting their healthcare benefits such as treating medical conditions and pain relieving properties. The U.S. Food and Drug Administration also approved the first cannabis-derived drug, Epidiolex, which is already being used to treat epilepsy in children. Overall, the combination of all of these recent events has exponentially accelerated the CBD marketplace. Moving forward, the CBD market is expected to continually grow as more countries began to adopt cannabis legalizations. According to data compiled by Brightfield Group, the U.S. CBD market is expected to reach USD 22 Billion by 2022. SinglePoint Inc. (OTC: SING), PotNetwork Holdings, Inc. (OTC: POTN), MassRoots, Inc. (OTC: MSRT) mCig, Inc. (OTC: MCIG), Medical Marijuana, Inc. (OTC: MJNA)

CBD is primarily being advertised as a medical supplement, however, some companies have taken the opportunity to integrate CBD into other products. Consumers can now find CBD in products such as beauty products, beverages, and even pet treats. Consumers can also take CBD purely for recreational purposes, to relax, as well as use it for medical applications. The wide range use of CBD creates a versatile market and expands outwards to many consumers. “A few years ago almost no one knew what hemp-derived CBD was, it was sold by mostly small brands of tinctures online and through head shops. All of a sudden, CBD is everywhere – it is both a trendy, new ingredient in drinks, face creams and pet treats and an answer to the prayers of so many people suffering from medical conditions ranging from epilepsy to anxiety and chronic pain. It rides the waves of so many global food and health trends, as a substitute for opioids, towards more natural health alternatives and functional ingredients,” said Bethany Gomez, Managing Director at Brightfield Group.

SinglePoint Inc. (OTCQB: SING) today announced, “the filing with the SEC of the Company’s first annual report as a fully reporting issuer. SinglePoint ended 2018 with total sales of $1,154,671 an increase of 344% compared to the previous year. The increase is largely due to the success of SinglePoint executing on its acquisition strategy. Over the last year the Company has solidified its’ financial position as well as become a fully reporting, audited issuer.

SinglePoint plans to continue its momentous growth with its latest Asset Purchase Agreement with Direct Solar. Direct Solar has seen tremendous growth over the past few months. SinglePoints’ auditing firm is currently reviewing the financial statements and upon completion will finalize the acquisition.

“We have spent a lot of time and effort to put the Company in a position to turn a profit in the very near future. With the anticipated acquisition of Direct Solar and the explosive growth we are seeing that goal could become a reality. We are excited about the future of SinglePoint and are in a stronger position now than we have ever been,” states Greg Lambrecht CEO.

About SinglePoint Inc: SinglePoint Inc (SING) is a technology and investment company with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration. The Company portfolio includes mobile payments, ancillary cannabis services and renewable energy solutions. Through acquisitions into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued companies, thereby providing a rich, diversified holding base.”

PotNetwork Holdings, Inc. (OTC: POTN) is a publicly traded company that acts as a holding company for its principal subsidiaries, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD products. Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. recently announced that it is presenting its popular line of Diamond CBD oils, edibles, and creams to several large pharmacy chains. Recently passed federal legislation that legalizes industrial hemp production in the United States has generated increased mainstream acceptance of CBD-based products and drawn interest from retailers looking to capitalize on the public’s desire for products that reduce stress and anxiety. “Our array of CBD products already play an active role in the wellness routine of thousands of Americans,” said Kevin Hagen, Chief Executive Officer of Diamond CBD parent company PotNetwork Holdings, Inc. “That’s why we are happy to present the benefits of CBD and our popular oils, edibles and beauty products to several large pharmacy chains in the days ahead.”

MassRoots, Inc. (OTCQB: MSRT) is a leading technology platform for the regulated cannabis industry. Marijuana Company of America recently announced that the Company’s wholly-owned subsidiary hempSMART has entered into a strategic marketing agreement with MassRoots, Inc. to promote its hemp CBD formulated product line. Under the terms of the agreement, MassRoots agreed to participate as an associate in the Company’s associate marketing platform, to help promote and sell hempSMART products on www.massroots.com, as well as MassRoots’ app and other social media outlets. “We’re excited to begin educating MassRoots’ community of over a million cannabis consumers about hempSMART’s innovative line of CBD products,” stated MassRoots’ Chief Executive Officer Isaac Dietrich. “We look forward to driving our audience to a company that focuses on providing consumers with the highest-quality of ingredients and products, which is ultimately why we’re partnering with MCOA.”

mCig, Inc. (OTCQB: MCIG), headquartered in Jacksonville, Florida, is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands. mCig, Inc. recently announced that its wholly-owned subsidiary, CBJ Distributing, is expanding its sales reach by introducing to its clients in Nevada and California a new in-house developed product line of hemp pre-rolled cigarettes and CBD vape pens with a proprietary terpene rich formula. CBJ Distributing saw its sales increase dramatically during the last year. The company distributes its line of cannabis supply items, such as: labels, jars, childproof envelopes, vape pens, to almost all dispensaries in Nevada, while enlarging its market share in southern and central California. After carefully analyzing the CBD market, CBJ Distributing decided to expand its product line by joining this huge opportunity of selling hemp products to smoke shops and dispensaries around the Country. “We have a strong team of professionals with boots to the ground, following the trends, growth, and needs of the market through client-based communication and customer service. Since its acquisition in May 2018, CBJ Distributing has consistently been the strongest division of MCIG, with a constant and continued growth in sales and profits. Our management team at CBJ Distributing gets results!” said Paul Rosenberg, Chief Executive Officer of MCIG. Mr. Rosenberg went on to say, “During the past month, the MCIG officers and Board of Directors have had multiple meetings in our Las Vegas office with the CBJ management team where we have identified the direction MCIG must take in order to be a top cannabis company going forward.”

Medical Marijuana, Inc. (OTC: MJNA) mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. Medical Marijuana, Inc. recently announced that its subsidiaries Kannaway®, HempMeds® and Dixie Botanicals all received Certification Seals from the U.S. Hemp Authority. To receive this seal, companies must have met several stringent industry standards laid out for quality and safety. The certification is intended to educate hemp farmers and producers about Food and Drug Administration Current Good Manufacturing Practices (cGMP) and Good Agricultural Practices (GAP) to guarantee that consistent quality is achieved. The U.S. Hemp Authority Certification Program is administered by experienced quality assurance and verification professionals from industry-leading food and agricultural companies. “We are honored to have received these Certification Seals for several of our subsidiaries,” said Medical Marijuana, Inc. Chief Executive Officer Dr. Stuart Titus. “Our customers’ safety is our priority and we are proud to have our high-quality manufacturing processes confirmed so that consumers understand that buying from us means that they have access to safe and accurately labeled hemp-derived products, including fiber, seed and extracts, such as cannabidiol (CBD).”

Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia

Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz

Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/

SOURCE FinancialBuzz.com

Fintech PR

FP Markets Awarded Best Forex Trading Tools 2023 by FXScouts

Published

8 mins ago

December 4, 2023

CISION (PR Newswire)

fp-markets-awarded-best-forex-trading-tools-2023-by-fxscouts

SYDNEY, Dec. 4, 2023 /PRNewswire/ — FP Markets has again been recognised for its outstanding trading solutions, receiving the Best Forex Trading Tools 2023 award from FXScouts. This accolade complements the company’s growing list of awards received this year, including ‘Best Trade Execution’ and ‘Most Transparent Broker’ at the Ultimate Fintech Awards APAC 2023. These prestigious awards further establish FP Markets as a leading broker dedicated to providing clients with the best possible trading experience. The company’s dedication to innovation is evident in its cutting-edge Trading Tools, which deliver a wide selection of features to assist traders and investors in navigating global financial markets more efficiently.

Founded in 2019, FxScouts.com is a well-known and respected organisation that helps traders discover top-rated Forex brokers. Boasting a global presence renowned for its rigorous and unbiased evaluation process, the company has independently tested and reviewed nearly 200 brokers and published wide-reaching Forex broker reviews.

Clients can access various Trading Tools with FP Markets, including Trading Central and Autochartist. Both are globally recognised powerhouses that deliver automated analytics. Additionally, traders can access a comprehensive Trader Toolbox for MT4 and MT5, a Trading Calculator designed with the trader in mind, and a suite of Trading Platforms, including MT4, MT5 and cTrader.

FP Markets Head of Content and Education, Aaron Hill, expressed his thoughts on the recent award, commenting: ‘This award recognises and highlights that the trader and investor’s needs come first at FP Markets, and the team are proud to have been acknowledged for their efforts. The ability to select from a wide range of trading tools to analyse and trade financial markets confidently and effectively is crucial for many traders and investors today. Gone are the days of sorting through charts to identify trading opportunities and manually calculating position size, margin and swap, for example. With FP Markets, you can employ easy-to-use Trading Tools to help streamline your trading process’.

Established in 2005, FP Markets is a Multi-Regulated Brand providing clients with over 10,000 tradable instruments across key asset classes and offers aggregate pricing across several top-tier liquidity providers. Additionally, FP Markets deliver Consistently Tight Spreads, Lightning Execution, Unmatched 24/7 Multilingual Customer Support, and various Account Types to suit all trading strategies and styles.

About FP Markets:

FP Markets is a Multi-Regulated Forex and CFDs Broker with over 18 years of industry experience.
The company offers highly competitive interbank Forex spreads starting from 0.0 pips.
Traders can choose from the leading powerful online trading platforms, including FP Markets’ Mobile App, MetaTrader 4, MetaTrader 5, WebTrader, cTrader, and Iress.
The company’s outstanding 24/7 multilingual customer service has been recognised by Investment Trends and awarded ‘The Highest Overall Client Satisfaction Award’ over five consecutive years.
FP Markets has been awarded the ‘Best Global Forex Value Broker’ for five consecutive years (2019, 2020, 2021, 2022, 2023) at the Global Forex Awards.
FP Markets has been awarded the ‘Best Forex Broker – Europe‘ and the ‘Best Forex Partners Programme – Asia‘ at the Global Forex Awards 2022 and 2023.
FP Markets has been awarded ‘Best Trade Execution’ at the Ultimate Fintech Awards 2022.
FP Markets crowned ‘Best CFD Broker in Africa‘ at FAME Awards 2023.

FP Markets Awarded ‘Best Trade Execution’ and ‘Most Transparent Broker’ at the Ultimate Fintech Awards APAC 2023

For more information on FP Markets’ comprehensive range of products and services, visit https://www.fpmarkets.com/.

Photo – https://mma.prnewswire.com/media/2292567/Best_Forex_Trading_Tools_Awards.jpg
Logo – https://mma.prnewswire.com/media/1574261/4438205/FP_Markets_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/fp-markets-awarded-best-forex-trading-tools-2023-by-fxscouts-302005151.html

Fintech PR

Banco Safra Files Lawsuit to Prevent Americanas and Its Controlling Shareholders from Moving Forward with Deficient Restructuring Plan

Published

1 hour ago

December 4, 2023

CISION (PR Newswire)

SAO PAULO, Dec. 4, 2023 /PRNewswire/ — Banco Safra today filed suit to prevent Americanas (the “Company”) and its controlling shareholders from moving forward with a deficient recovery plan that it believes would be nullified by the Judiciary.

Americanas and its controlling shareholders, Lemann, Telles and Sicupira, have proposed a recovery plan that seeks to prevent creditors from continuing to investigate the true causes of the fraud perpetrated at the Company. Banco Safra believes this clause is an illegal effort by the Company and its controlling shareholders to avoid accountability for the fraud and are challenging the legality of the recovery plan.

In January 2023, Americanas named Sérgio Rial as Chief Executive Officer. Rial was new to Americanas. Less than 10 days into his new role, he uncovered what he and others believed to be a massive fraud multiple times larger than the company’s net equity, resulting in the company filing for insolvency protection. Lemann, Telles and Sicupira claim that they, like the Company’s creditors, are victims of the fraud and have asserted that they were not aware of any wrongdoing at the company. They have made this claim even though they and their children sat on the Board of Directors of Americanas and have been overseeing the company and working with the executives who allegedly perpetrated the fraud for over 20 years.

To substantiate this assertion, the Board of Directors of Americanas handpicked an “Independent Committee” to investigate the alleged fraud. This Committee reports to the very same Board that oversaw the Company when the fraud was committed and has the contradictory mandate of investigating the same individuals who appointed it. This is a blatant conflict of interest and incongruent with basic corporate governance standards.

The Company and the controlling shareholders have now presented a new recovery plan that would result in creditors being repaid a fraction of what they are contractually owed on a commitment not to litigate or investigate against the controlling shareholders and their families and other directors of Americanas.

The controlling shareholders have the financial resources to fully repay creditors for all funds lost. Instead, as part of the recovery plan, they have proposed a capital injection that amounts to less than one third of the total value of the fraud and an insignificant amount in relation to their assets. In a coercive attempt to avoid fulfilling their obligations, creditors must agree to end the investigations into the fraud to benefit from this capital injection.

This illegal clause is just one of multiple deficiencies Banco Safra believes should nullify the entire Americanas recovery plan as set forth in the suit we filed today.

Media Contact
Robert Siegfried / Ross Lovern
Kekst CNC
212-521-4800

View original content:https://www.prnewswire.co.uk/news-releases/banco-safra-files-lawsuit-to-prevent-americanas-and-its-controlling-shareholders-from-moving-forward-with-deficient-restructuring-plan-302005020.html

Fintech PR

Collagen Gummy Sales Propelled by Convenience, Taste, and Health Benefits to Reach US$378 Million by 2033 | Future Market Insights, Inc.

Published

2 hours ago

December 4, 2023

CISION (PR Newswire)

collagen-gummy-sales-propelled-by-convenience,-taste,-and-health-benefits-to-reach-us$378-million-by-2033-|-future-market-insights,-inc.

NEWARK, Del., Dec. 4, 2023 /PRNewswire/ — A study by FMI attributes the flourishing global collagen gummy market to rising consumer awareness of the convenience, palatability, and health benefits of collagen gummies. Key players are actively engaging in mergers and collaborations to develop innovative products and maintain their market dominance, ensuring a dynamic and competitive landscape.

Explore further to gain comprehensive insights into the global collagen gummy market.

A Detailed Analysis of the Collagen Gummy Market by Berry and Citrus Flavors, from 2023 to 2033

The global collagen gummy market value is projected to reach US$ 247 million in 2023 and US$ 378 million by 2033. Over the forecast period, global demand for collagen gummies is anticipated to surge at 4.3% CAGR.

Get an Exclusive Sample Copy of the Collagen Gummies Market, 2023-2033: https://www.futuremarketinsights.com/reports/sample/REP-GB-18539

Several factors are expected to stimulate the growth of the collagen gummy market during the forecast period. These include growing awareness about the convenience, palatability, and health benefits of collagen gummies, rising health awareness, and easy availability through online platforms.

People worldwide are becoming aware about the health and cosmetic advantages of collagen supplement intake. As a result, demand for collagen gummies is rising significantly, and the trend is expected to continue through 2033.

Collagen gummies are believed to positively impact skin health, hair growth, joint health, and wound healing. This prompts people to consume these health supplements, bolstering their sales.

Rising health and wellness trends and interest in nutricosmetics will further boost the global collagen gummy industry. Similarly, new product launches and expanding e-commerce are expected to create growth prospects for collagen gummy companies.

Key companies are focusing on using celebrity endorsements to reach a wider audience and boost their sales. This will bode well for the target market.

Key Takeaways from the Global Collagen Gummy Market Study Report

The global collagen gummy market is set to total US$ 378 million in 2033.
By flavor type, the berry segment is projected to hold a value share of 34% in 2023.
Based on functionality, promoting skin health segment will likely account for about 25% of market share in 2023.

Understand global, regional, and country-level parameters with growth opportunities, historical data (2018-2022), and forecasts (2023-2033). Buy this report today!

Demand for collagen gummies in India is anticipated to rise at a CAGR of 6.2%.
The United States holds around 30.8% of the global market share.
Sales of collagen gummies in the United Kingdom are predicted to increase at 5.6% CAGR through 2033.
China is poised to exhibit a CAGR of 6.1% from 2023 to 2033.

“The global market for collagen gummies is expected to witness steady growth amid rising awareness about the benefits of collagen. Widespread advertising of processed collagen supplements by the manufacturers can be instrumental in boosting the popularity of collagen gummies in the low-income group countries,” says Nandini Roy Choudhury (Client Partner for Food & Beverages at Future Market Insights, Inc.).

Who is Winning?

The global collagen gummy market is highly consolidated, with most of suppliers concentrated in North America and Europe. However, the unavailability of sufficient sources of collagen in these regions is gradually shifting the business to Asian and African countries. This, in turn, has encouraged several regional collagen processing industries to enter the collagen gummy sector, which could diversify the market gradually.

Key players are adopting a wide variety of strategies to boost their sales and expand their global footprint. These include new product launches, mergers, celebrity endorsements, acquisitions, partnerships, and collaborations.

Recent Developments in the Collagen Gummy Industry:

In June 2020, Novomins Nutrition Inc. introduced its new product line of collagen gummies for its consumers. The company claims that the gummies contain hyaluronic acid, biotin, and vitamin C and are devoid of gluten and GMOs, artificial coloring, or sweeteners.
In November 2020, a new startup was established as the first cell-based collagen and Gelatin Company named Jellatech. The company was founded by Stephanie Michelsen and Kylie van Deinsen-Hesp, who claim to make gelatin and collagen using cellular agriculture and without animal products.

Purchase this report now to get key companies with their Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis.

Get More Valuable Insights

Future Market Insights (FMI), in its new offering, provides an unbiased analysis of the global collagen gummy market presenting historical demand data (2018 to 2022) and forecast statistics for the period from 2023 to 2033.

The study incorporates compelling insights on the collagen gummy industry based on flavor type, source, functionality, and sales channel across several regions.

About the Food and Beverage Division at Future Market Insights (FMI)

Expert analysis, actionable insights, and strategic recommendations – the food and beverages team at Future Market Insights (FMI) helps clients from all over the globe with their unique business intelligence needs. With a repertoire of over 1,000 reports and 1 million+ data points, the team has analyzed the food and beverage industry lucidly in 50+ countries for over a decade. The team provides end-to-end research and consulting services; reach out to explore how we can help.

About the Author:

Nandini Roy Choudhury (Client Partner for Food & Beverages at Future Market Insights, Inc.) has 7+ years of management consulting experience. She advises industry leaders and explores off-the-eye opportunities and challenges. She puts processes and operating models in place to support their business objectives.

She has exceptional analytical skills and often brings thought leadership to the table.

Nandini has vast functional expertise in key niches, including but not limited to food ingredients, nutrition & health solutions, animal nutrition, and marine nutrients. She is also well-versed in the pharmaceuticals, biotechnology, retail, and chemical sectors, where she advises market participants to develop methodologies and strategies that deliver results.

Her core expertise lies in corporate growth strategy, sales and marketing effectiveness, acquisitions and post-merger integration and cost reduction. Nandini has an MBA in Finance from MIT School of Business. She also holds a Bachelor’s Degree in Electrical Engineering from Nagpur University, India.

Nandini has authored several publications, and quoted in journals including Beverage Industry, Bloomberg, and Wine Industry Advisor.

Explore FMI’s Extensive Coverage in the Food and Beverages Domain:

Sugar-Free Sweets Market to Reach US$3.9 Billion by 2033, Driven by Health Consciousness and Rising Demand for Alternative Sweeteners. – Get a Sample Report Copy.
Driven by growing demand for health and wellness products, the collagen peptide market is projected to reach US$1.23 billion by 2033. – Get a Sample Report Copy.
Global collagen supplement market is projected to expand at a compound annual growth rate (CAGR) of 6.4% reaching a valuation of US$ 2.8 billion by 2032. – Get a Sample Report Copy.
The sugar-free gummy market is projected to reach a valuation of US$1,040 million by 2033, expanding at a CAGR of 5.2% from an estimated US$627 million in 2023. – Get a Sample Report Copy.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the United Kingdom, the United States, and India. FMI’s latest market research reports and industry analysis helps businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition.

Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us
Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: [email protected]
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube